Measuring nicotine intake among highly-dependent adolescent smokers: Comparability of saliva and plasma cotinine concentrations

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 2, 2008, Pages 145-149

  Parzynski, Craig S ^a   Jaszyna Gasior, Maria ^a   Franken, Frederick H ^a   Moolchan, Eric T ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Adolescents; Bioverification; Cotinine; Nicotine Dependence

Indexed keywords

COTININE; NICOTINE; PLACEBO;

ADOLESCENT; ADOLESCENT SMOKING; AGE DISTRIBUTION; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; COTININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HUMAN; MALE; MULTIPLE REGRESSION; NICOTINE REPLACEMENT THERAPY; PLASMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVA LEVEL; SEX RATIO; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADOLESCENT; AGING; COTININE; DATA INTERPRETATION, STATISTICAL; ETHNIC GROUPS; FEMALE; HUMANS; MALE; SALIVA; SALIVATION; SEX CHARACTERISTICS; SMOKING; TOBACCO USE DISORDER;

EID: 39149116722     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.12.003     Document Type: Article

References (35)

1. Benowitz N.L., and Jacob III P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 56 (1994) 483-493
2. Berlin I., Gasior M.J., and Moolchan E.T. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine Tob Res 9 (2007) 493-498
3. Bramer S.L., and Kallungal B.A. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 8 (2003) 187-4903
4. CDC. Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. Morb Mort Weekly Report 54 (2005) 625-628
5. CDC. Youth risk behavior surveillance-United States, 2005. Surveillance Summaries, MMWR vol. 55 (2006), U.S. Department of Health and Human Services SS5
6. Cone E. Saliva testing for drugs of abuse. Reprinted from saliva as a diagnostic fluid. Annals of the New York Academy of Sciences 694 (1993) 91-127
7. Curvall M., Elwin C.E., Kazemi-Vala E., Warholm C., and Enzell C.R. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 38 (1990) 281-287
8. Dolcini M.M., Adler N.E., Lee P., and Bauman K.E. An assessment of the validity of adolescent self-reported smoking using three biological indicators. Nicotine Tob Res 5 (2003) 473-483
9. Eskenazi B., Prehn A.W., and Christianson R.E. Passive and active maternal smoking as measured by serum cotinine: the effect on birthweight. Am J Public Health 85 (1995) 395-398
10. Feyerabend C., and Russell M.A. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 42 (1990) 450-452
11. Fenoll-Palomares C., Munoz-Montagud V., Sanchiz V., Herreros B., Hernandez V., Minguez M., et al. Unstimulated salivary flow rate, pH and buffer capacity of saliva in health volunteers. Rev Esp Enferm Dig 96 (2004) 773-783
12. Godtfredsen N.S., Prescott E., Vestbo J., and Osler M. Smoking reduction and biomarkers in two longitudinal studies. Addiction 101 (2006) 1516-1522
13. Hanson K., Allen S., Jensen S., and Hatsukami D. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob Res 5 (2003) 515-526
14. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction 86 (1991) 1119-1127
15. Hurt R.D., Croghan G.A., Beede S.D., Wolter T.D., Croghan I.T., and Patten C.A. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Arch Pediatr Adolesc Med 154 (2000) 31-37
16. Jacob III P., Shulgin A.T., Yu L., and Benowitz N.L. Determination of the nicotine metabolite trans-3'-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr 583 (1992) 145-154
17. Jarvis M.J., Primatesta P., Erens B., Feyerabend C., and Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res 5 (2003) 349-355
18. Johnstone E., Benowitz N., Cargill A., Jacob R., Hinks L., Day I., et al. Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther 80 (2006) 319-330
19. Krishnan-Sarin S., Duhig A.M., McKee S.A., McMahon T.J., Liss T., McFetridge A., et al. Contingency management for smoking cessation in adolescent smokers. Exp Clin Psychopharmacol 14 (2006) 306-310
20. Moolchan E.T., and Mermelstein R. Research on tobacco use among teenagers: ethical challenges. J Adolesc Health 30 (2002) 409-417
21. Moolchan E.T., Robinson M.L., Ernst M., Cadet J.L., Pickworth W.B., Heishman S.J., et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 115 (2005) e407-e414
22. Moolchan E.T., Franken F.H., and Jaszyna-Gasior M. Adolescent nicotine metabolism: ethnoracial differences among dependent smokers. Ethn Dis 16 (2006) 239-243
23. National Center for Health Statistics. Health, United States. 2005 with Chartbook on Trends in the Health of Americans (1994), Department of Health and Human Services (DHHS), Hyattsville, MD
24. Patrick D.L., Cheadle A., Thompson D.C., Diehr P., Koepsell T., and Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 84 (1994) 1086-1093
25. Rose J.E., Levin E.D., and Benowitz N. Saliva nicotine as an index of plasma levels in nicotine skin patch users. Ther Drug Monit 15 (1993) 431-435
26. SAMHSA. Results from the 2004 National Survey on Drug Use and Health: (Office of Applied Studies) (2005), : U.S. Department of Health and Human Services, Rockville, Maryland NSDUH Series H-27
27. Schneider N.G., Jacob III P., Nilsson F., Leischow S.J., Benowitz N.L., and Olmstead R.E. Saliva cotinine levels as a function of collection method. Addiction 92 (1997) 347-351
28. Simoni M., Baldacci S., Puntoni R., Pistelli F., Farchi S., Lo Presti E., et al. Plasma, salivary and urinary cotinine in non-smoker Italian women exposed and unexposed to environmental tobacco smoking (SEASD study). Clin Chem Lab Med 44 (2006) 632-638
29. Soderling E., Pienihakkinen K., Alanen M.L., Hietaoja M., and Alanen P. Salivary flow rate, buffer effect, sodium, and amylase in adolescents: a longitudinal study. Scand J Dent Res 101 (1993) 98-102
30. SRNT. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4 (2002) 149-159
31. St Charles F.K., Krautter G.R., Dixon M., and Mariner D.C. A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacology 189 (2006) 345-354
32. Stevens S.L., Colwell B., Smith D.W., Robinson J., and McMillan C. An exploration of self-reported negative affect by adolescents as a reason for smoking: implications for tobacco prevention and intervention programs. Prev Med 41 (2005) 589-596
33. Teeuwen H.W., Aalders R.J., and Van Rossum J.M. Simultaneous estimation of nicotine and cotinine levels in biological fluids using high-resolution capillary-column gas chromatography combined with solid phase extraction work-up. Mol Biol Rep 13 (1988) 165-175
34. U.S. Department of Health and Human Services. Preventing Tobacco Use Among Young People: a Report of the Surgeon General (1994), U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, Georgia
35. Yeh C.K., Johnson D.A., and Dodds M.W. Impact of aging on human salivary gland function: a community-based study. Aging 10 (1998) 421-428